Stockreport

IMUNON Reports 2023 Financial Results and Provides Business Update [Yahoo! Finance]

Imunon, Inc.  (IMNN) 
PDF clinical-stage drug-development company focused on developing DNA-mediated immuno-oncology therapies and next-generation vaccines, today reported financial results for t [Read more]